{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-23-002071","form_type":"8-K","ticker":"ELAN","cik":"0001739104","company_name":"Elanco Animal Health Inc","filed_at":"2023-01-09T23:59:59+00:00","discovered_at":"2026-05-14T18:03:46.361388+00:00","generated_at":"2026-06-20T18:02:06.416246+00:00","sec_items":["7.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"confidence":"medium","headline":"Elanco discloses FDA submission for JAK inhibitor at JPM conference","bullets":["Company notes Q4 2022 submission to FDA for its JAK inhibitor.","Presentation made at 41st Annual J.P. Morgan Healthcare Conference on Jan 10, 2023.","No financial results or guidance changes provided in the filing."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-23-002071","json":"https://secwatch.observer/filing/0001104659-23-002071.json","markdown":"https://secwatch.observer/filing/0001104659-23-002071.md","text":"https://secwatch.observer/filing/0001104659-23-002071.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1739104/000110465923002071/0001104659-23-002071-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1739104/000110465923002071/tm232554d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-20T18:02:06.416246+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}